0001209191-19-033695.txt : 20190531 0001209191-19-033695.hdr.sgml : 20190531 20190531171238 ACCESSION NUMBER: 0001209191-19-033695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190510 FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JACOBS JOEY A CENTRAL INDEX KEY: 0001243878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 19871376 MAIL ADDRESS: STREET 1: 830 CRESCENT CENTER DRIVE STREET 2: SUITE 610 CITY: FRANKLIN STATE: TN ZIP: 37067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-10 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001243878 JACOBS JOEY A 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2019-05-10 4 P 0 931 5.92 A 82651 D Common Stock 2019-05-13 4 P 0 526 5.67 A 83177 D Common Stock 2019-05-14 4 P 0 66 5.48 A 83243 D Common Stock 2019-05-15 4 P 0 677 6.00 A 83920 D Common Stock 2019-05-16 4 P 0 301 5.99 A 84221 D Common Stock 2019-05-17 4 P 0 794 6.20 A 85015 D Common Stock 2019-05-20 4 P 0 850 6.89 A 85865 D Common Stock 2019-05-21 4 P 0 850 6.49 A 86715 D Common Stock 2019-05-22 4 P 0 850 6.49 A 87565 D Common Stock 2019-05-23 4 P 0 850 6.44 A 88415 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Joey A. Jacobs by /s/ Michael Bonner as attorney-in-fact 2019-05-31